Be Pharmaceuticals Private Limited - Company Profile

Q: Where is Be Pharmaceuticals Private Limited headquartered?

Be Pharmaceuticals Private Limited is headquartered at 181 & 3, Azamabad,, Hyderabad, Telangana, 500020.

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2011.

2011 Hyderabad, Telangana, India Active

Last Updated: December 20, 2025

About Be Pharmaceuticals Private Limited

Be Pharmaceuticals Private Limited, a active private limited company, was established on 29 August 2011 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TG2011PTC148362. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹5.01 Cr.

Formerly known as Akorn India Private Limited. It upholds a compliant status. Employing 3 professional, Its leadership includes Rudaraju Anand Kumar (Director), Mahipal Reddy Saddi (Director), Mahima Datla (Director). Past directors included Dheeraj Chopra, Nilesh Pravin Gandhi, Rudaraju Anand Kumar. It holds no open charges and ₹20.00 Cr settled loans. Its latest AGM occurred on 18 September 2024, with the balance sheet filed on 31 March 2024. It is based at 18/1 & 3, Azamabad,, Hyderabad, Telangana, 500020.

Company Details

CIN/LLPIN
U24100TG2011PTC148362
Registration Number
148362
Incorporation Date
29 August 2011
Authorized Capital
₹6.00 Cr
Paid-Up Capital
₹5.01 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 6.00 Cr as on 20-12-2025
Paid Up Capital ₹ 5.01 Cr as on 20-12-2025
Company Age 14 Year, 5 Months
Last Filing with ROC 31 Mar 2024
Satisfied Charges ₹ 20.00 Cr as on 20-12-2025
Revenue Growth **** 8.85% (FY 2024)
Profit Growth **** 381.89% (FY 2024)
Ebitda **** 10.03% (FY 2024)
Net Worth 3.16% (FY 2024)
Total Assets -40.88% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Be Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Be Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Rudaraju Anand Kumar	Director	14 Aug 2020	Current
Mahipal Reddy Saddi	Director	26 Aug 2020	Current
Mahima Datla	Director	14 Aug 2020	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Whole-Time Director	14 Aug 2020	Past
Pramod Abcsdd	Director	28 Sep 2011	Past
Pramod Abcsdd	Additional Director	17 Aug 2020	Past
Pramod Abcsdd	Additional Director	04 Sep 2020	Past
Pramod Abcsdd	Additional Director	17 Aug 2020	Past
Pramod Abcsdd	Additional Director	01 Feb 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Be Pharmaceuticals.

Be Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 8.85% increase. The company also saw a substantial improvement in profitability, with a 381.89% increase in profit. The company's net worth moved up by a moderate rise of 3.16%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

8.85%

*******

Revenue from Operations

*******

53.34%

*******

Total Assets

*******

-40.88%

*******

Profit or Loss

*******

381.89%

*******

Net Worth

*******

3.16%

*******

EBITDA

*******

10.03%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Be Pharmaceuticals?

In 2024, Be Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹200,000,000.00

Charges Breakdown by Lending Institutions

Icici Bank Limited : 20.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
25 Jul 2014	Icici Bank Limited	₹20.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Be Pharmaceuticals?

Be Pharmaceuticals has a workforce of 3 employees as of Mar 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Be Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Be Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Be Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

Be Pharmaceuticals Private Limited last Annual general meeting of members was held on 18 Sep 2024 as per latest MCA records. was recorded as a recent event.
18 Sep 2024
Balance Sheet

Progress on Be Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
31 Mar 2024
Director Appointment

Mahipal Reddy Saddi was appointed as a Director was appointed as a Director on 26 Aug 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
26 Aug 2020
Director Appointment

Rudaraju Anand Kumar was appointed as a Director was appointed as a Director on 14 Aug 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
14 Aug 2020
Director Appointment

Progress on Mahima Datla was appointed as a Director was appointed as a Director on 14 Aug 2020 & has been associated with this company since 5 years 5 months . was documented.
14 Aug 2020
Charges

A charge registered on 25 Jul 2014 via Charge ID 10522225 with Icici Bank Limited was fully satisfied on 29 Jan 2015. was recorded as a recent event.
29 Jan 2015

Explore recent activity and updates - View Recent Activity